Skip to main content
Beni-Suef University Journal of Basic and Applied Sciences
Fig. 4 | Beni-Suef University Journal of Basic and Applied Sciences

Fig. 4

From: Clinical and biological significance of microRNA-127 and microRNA-138 expression in women with breast cancer: response to treatment and survival impact

Fig. 4

Kaplan–Meier survival curve for progression-free survival with miR-138 and miR-127. a A total of 75 Breast cancer patients were segregated into two groups (above median: n = 45, below median: n = 30) based on the expression status of miR-138. The progression-free survival time at the end of the study was insignificantly different between patients with below median (< 12.18) miRNA 138 levels (mean = 23.271, 62.9%) and patients with above median (> 12.18) miRNA 138 levels (mean = 26.284, 70.2%) (P = 0.504). b A total of 75 Breast cancer patients were segregated into two groups (above median: n = 46, below median: n = 29) based on the expression status of miR-127. The progression-free survival time at the end of the study was significantly shorter in patients with below median (< 11.31) miRNA 127 levels (mean = 18.855, 51.9%) compared to patients with above median (> 11.31) miRNA 127 levels (mean = 28.865, 81.1%) (P = 0.007)

Back to article page